Hudson Bay Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	–	–	988
2022 Q4	–	Sell	-330,000	Closed	-$3.03M	–	1106
2022 Q3	$3.89M	Sell	330,000 -70,000	-18%	-$947K	0.04%	519
2022 Q2	$4.52M	Buy	400,000 +20,000	+5%	+$402K	0.04%	473
2022 Q1	$11.4M	Sell	380,000 -20,000	-5%	-$541K	0.16%	117
2021 Q4	$10.6M	Buy	400,000 +119,000	+42%	+$3.59M	0.12%	123
2021 Q3	$10.2M	Buy	281,000 +31,000	+12%	+$1.22M	0.14%	121
2021 Q2	$10.8M	Sell	250,000 -4,490	-2%	-$170K	0.14%	116
2021 Q1	$8.7M	Sell	254,490 -29,010	-10%	-$1.15M	0.12%	143
2020 Q4	$9.92M	Sell	283,500 -35,000	-11%	-$1.01M	0.13%	120
2020 Q3	$7.64M	Sell	318,500 -13,385	-4%	-$329K	0.13%	155
2020 Q2	$6.07M	Sell	331,885 -18,115	-5%	-$326K	0.11%	174
2020 Q1	$5.46M	Buy	350,000 +50,000	+17%	+$1.06M	0.14%	140
2019 Q4	$6.42M	Buy	300,000 +25,000	+9%	+$515K	0.16%	139
2019 Q3	$5.14M	Buy	275,000 +52,000	+23%	+$1.07M	0.15%	145
2019 Q2	$5.82M	Buy	223,000 +10,000	+5%	+$226K	0.16%	153
2019 Q1	$5.47M	Buy	213,000 +3,000	+1%	+$68.6K	0.16%	254
2018 Q4	$4.83M	Buy	210,000 +14,500	+7%	+$409K	0.14%	305
2018 Q3	$6.28M	Sell	195,500 -4,500	-2%	-$135K	0.16%	235
2018 Q2	$5.66M	Buy	200,000 +75,000	+60%	+$2.67M	0.16%	248
2018 Q1	$4.42M	Hold	125,000	–	–	0.17%	259
2017 Q4	$4.85M	Hold	125,000	–	–	0.17%	167
2017 Q3	$3.17M	Buy	125,000 +25,000	+25%	+$608K	0.13%	198
2017 Q2	$2.73M	Buy	100,000 +85,000	+567%	+$2.33M	0.11%	294
2017 Q1	$497K	Buy	+15,000	New	+$382K	0.02%	698